Regal Assets Analytics

BTAI

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-10-20T14:21:50-04:00July 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , , , , , , , , , , , , , , , , |

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]

Bioxcel Rockets After Suntrust Upgrade; Agile Volatile Ahead Of FDA Decision

By |2020-03-30T10:12:21-04:00February 14th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , |

BioXcel Therapeutics (NASDAQ:BTAI) soared this morning to about $38 per [...]

BioXcel Therapeutics (BTAI) Probability Sentiment

By |2020-10-20T14:52:26-04:00December 20th, 2019|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

STOCK SYMBOL Probability Sentiment SUMMARY [...]